Functional characterization and immunomodulatory properties of Lactobacillus helveticus strains isolated from Italian hard cheeses
- 2021-01-25
- PLOS ONE 16(1)
- M. Zago
- L. Massimiliano
- B. Bonvini
- G. Penna
- G. Giraffa
- M. Rescigno
- PubMed: 33493208
- DOI: 10.1371/journal.pone.0245903
Abstract
Lactobacillus helveticus carries many properties such as the ability to survive gastrointestinal transit, modulate the host immune response, accumulate biopeptides in milk, and adhere to the epithelial cells that could contribute to improving host health. In this study, the applicability as functional cultures of four L. helveticus strains isolated from Italian hard cheeses was investigated. A preliminary strain characterization showed that the ability to produce folate was generally low while antioxidant, proteolytic, peptidase, and β-galactosidase activities resulted high, although very variable, between strains. When stimulated moDCs were incubated in the presence of live cells, a dose-dependent release of both the pro-inflammatory cytokine IL-12p70 and the anti-inflammatory cytokine IL-10, was shown for all the four strains. In the presence of cell-free culture supernatants (postbiotics), a dose-dependent, decrease of IL-12p70 and an increase of IL-10 was generally observed. The immunomodulatory effect took place also in Caciotta-like cheese made with strains SIM12 and SIS16 as bifunctional (i.e., immunomodulant and acidifying) starter cultures, thus confirming tests in culture media. Given that the growth of bacteria in the cheese was not necessary (they were killed by pasteurization), the results indicated that some constituents of non-viable bacteria had immunomodulatory properties. This study adds additional evidence for the positive role of L. helveticus on human health and suggests cheese as a suitable food for delivering candidate strains and modulating their anti-inflammatory properties.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus helveticus | Modulated Immune Response | Beneficial | Moderate |
Lactobacillus helveticus | Reduced Inflammation Levels | Beneficial | Moderate |
Lactobacillus helveticus L10 | Modulated Immune Response | Beneficial | Moderate |
Lactobacillus helveticus L10 | Reduced Inflammation Levels | Beneficial | Moderate |
Lactobacillus helveticus LH76 | Increased IL-10 Levels | Beneficial | Large |
Lactobacillus helveticus LH76 | Reduced IL-12p70 Release | Beneficial | Large |
Lactobacillus helveticus Rosell-52 ME | Enhanced Anti-inflammatory Properties | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52 ME | Increased Anti-Inflammatory Cytokine Levels | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52 ME | Increased Pro-inflammatory Cytokine Release | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52 ME | Reduced Pro-inflammatory Cytokine Release | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Modulated Immune Response | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Reduced Inflammation Levels | Beneficial | Moderate |
Lactobacillus helveticus VPro 13 | Adherence to Epithelial Cells | Beneficial | Moderate |
Lactobacillus helveticus VPro 13 | Gastrointestinal Survival | Beneficial | Moderate |
Lactobacillus helveticus VPro 13 | Modulated Immune Response | Beneficial | Moderate |